Publication | Closed Access

Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

Advanced HeadNeck CancerRadiation TherapyConcurrent Weekly CisplatinMedicineHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyTreatment ResistanceRadiologyHealth Sciences